Table 1.
Baseline characteristics of participants infected with Omicron.
| N | 847 |
|---|---|
| Age, Median (IQR) | 62 (41–73) |
| ≤70 yrs | 690 (69.66) |
| >70 yrs | 257 (30.34) |
| Male, N (%) | 392 (46.28) |
| Vaccination, N (%) * | 607 |
| Unvaccinated | 319 (52.55) |
| Partially vaccinated | 20 (3.29) |
| Fully vaccinated | 130 (21.42) |
| Booster | 138 (22.73) |
| Comorbidities, N (%) | |
| Heart conditions | 257 (30.34) |
| Metabolic disease | 157 (18.54) |
| CKD stage 4–5 | 156 (18.42) |
| Isolated hypertension | 145 (17.12) |
| Cancer | 106 (12.51) |
| Cerebral vascular disease | 62 (7.32) |
| Lung disease | 62 (7.32) |
| Neurodegenerative disease | 36 (4.25) |
| Acute conditions | 40 (4.72) |
| Bone fracture | 16 (1.89) |
| Autoimmune diseases | 6 (0.71) |
| Comorbidities, N (%) | |
| 0 | 293 (34.59) |
| 1 | 219 (25.86) |
| 2 | 204 (24.09) |
| ≥3 | 131 (15.47) |
| Long-term bedridden, N (%) | 161 (19.01) |
| Treatment, N (%) | |
| Oxygen inhalation | 210 (24.79) |
| High flow or BIPAP | 4 (0.47) |
| Mechanical ventilations | 11 (1.3) |
| Hemodialysis | 136 (16.06) |
| Glucocorticoid | 106 (12.51) |
| Outcome | |
| Severe/Critical cases, N (%) | 93 (10.98) |
| Viral shedding time, median (IQR) | 13 (10–16) |
* 607 participants reported received doses of COVID-19 vaccine.
Abbreviation: CKD: Chronic Kidney Disease; yrs: years old.